BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 18344210)

  • 1. Partial splenic embolization for cancer patients with thrombocytopenia requiring systemic chemotherapy.
    Kauffman CR; Mahvash A; Kopetz S; Wolff RA; Ensor J; Wallace MJ
    Cancer; 2008 May; 112(10):2283-8. PubMed ID: 18344210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial splenic embolization in the treatment of prolonged thrombocytopenia due to hypersplenism in metastatic cancer patients.
    Passhak M; Shachar SS; Ofer A; Beny A
    Support Care Cancer; 2018 Oct; 26(10):3527-3532. PubMed ID: 29696427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term portal hemodynamic effects of partial splenic embolization for hypersplenism.
    Chikamori F; Kuniyoshi N; Kawashima T; Takase Y
    Hepatogastroenterology; 2007 Sep; 54(78):1847-9. PubMed ID: 18019732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term follow-up for patients with liver cirrhosis after partial splenic embolization.
    Murata K; Shiraki K; Takase K; Nakano T; Tameda Y
    Hepatogastroenterology; 1996; 43(11):1212-7. PubMed ID: 8908553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial splenic embolization with Glubran
    Loffroy R; Falvo N; Nakaï M; Pescatori L; Aho-Gléglé S; Gehin S; Berthod PE; Né R; Vincent J; Ghiringhelli F; Midulla M; Chevallier O
    Quant Imaging Med Surg; 2019 Mar; 9(3):409-417. PubMed ID: 31032188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients.
    Hayashi H; Beppu T; Masuda T; Mizumoto T; Takahashi M; Ishiko T; Takamori H; Kanemitsu K; Hirota M; Baba H
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1638-42. PubMed ID: 17683504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic splenectomy may be a superior supportive intervention for cirrhotic patients with hypersplenism.
    Tomikawa M; Akahoshi T; Sugimachi K; Ikeda Y; Yoshida K; Tanabe Y; Kawanaka H; Takenaka K; Hashizume M; Maehara Y
    J Gastroenterol Hepatol; 2010 Feb; 25(2):397-402. PubMed ID: 19929930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial splenic embolization for the treatment of hypersplenism in cirrhosis.
    Sangro B; Bilbao I; Herrero I; Corella C; Longo J; Beloqui O; Ruiz J; Zozaya JM; Quiroga J; Prieto J
    Hepatology; 1993 Aug; 18(2):309-14. PubMed ID: 8340060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 patients.
    Zhu K; Meng X; Qian J; Huang M; Li Z; Guan S; Jiang Z; Shan H
    Dig Liver Dis; 2009 Jun; 41(6):411-6. PubMed ID: 19070555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of preoperative partial splenic embolization in hepatocellular carcinoma and hypersplenic thrombocytopenia.
    Yoshidome H; Kimura F; Shimizu H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Takeuchi D; Takayashiki T; Suda K; Takano S; Miyazaki M
    Hepatogastroenterology; 2011; 58(112):2062-6. PubMed ID: 22234078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new volumetric evaluation of partial splenic embolization for hypersplenism in biliary atresia.
    Obatake M; Muraji T; Kanegawa K; Satoh S; Nishijima E; Tsugawa C
    J Pediatr Surg; 2001 Nov; 36(11):1615-6. PubMed ID: 11685685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of hypersplenism by partial splenic embolization with ethylene vinyl alcohol copolymer.
    Gonsalves CF; Mitchell EP; Brown DB
    AJR Am J Roentgenol; 2010 Nov; 195(5):1241-4. PubMed ID: 20966334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transradial approach for partial splenic embolization in patients with hypersplenism.
    Naritaka Y; Shiozawa S; Shimakawa T; Wagatsuma Y; Tsuchiya A; Kim DH; Isohata N; Asaka S; Yoshimatsu K; Katsube T; Ogawa K
    Hepatogastroenterology; 2007 Sep; 54(78):1850-3. PubMed ID: 18019733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial splenic embolization: 12-month hematological effects and complications.
    Wang HY; Shih SC; Lin SC; Chang WS; Wang TE; Lin FJ; Yang FS
    Hepatogastroenterology; 2008; 55(86-87):1838-42. PubMed ID: 19102404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large splenic volume may be a useful predictor for partial splenic embolization-induced liver functional improvement in cirrhotic patients.
    Hayashi H; Beppu T; Masuda T; Okabe H; Imai K; Hashimoto D; Ikuta Y; Chikamoto A; Watanabe M; Baba H
    J Hepatobiliary Pancreat Sci; 2014 Jan; 21(1):51-7. PubMed ID: 23798315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial splenic embolization. An effective alternative to splenectomy for hypersplenism.
    Shah R; Mahour GH; Ford EG; Stanley P
    Am Surg; 1990 Dec; 56(12):774-7. PubMed ID: 2268105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of laparoscopic splenectomy as salvage treatment for relapsed thrombocytopenia after partial splenic arterial embolization.
    Hashimoto N; Akahoshi T; Tomikawa M; Kawanaka H; Konishi K; Uehara H; Kinjo N; Korenaga D; Takenaka K; Maehara Y
    Dig Surg; 2010; 27(6):515-20. PubMed ID: 21196735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial splenic embolization decreases the serum bilirubin level in patients with hypersplenism following the Kasai procedure for biliary atresia.
    Ando H; Ito T; Nagaya M
    J Am Coll Surg; 1996 Mar; 182(3):206-10. PubMed ID: 8603238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful management of thrombocytopenia by partial splenic embolization in patients with advanced gastric cancer and invasion of the splenic vein: Case reports.
    Nakatsubo R; Yamauchi Y; Hiraizumi T; Naruse F; Kanda R; Suzuki Y; Kakegawa T; Kurosawa T; Yoshimasu Y; Saguchi T; Sofuni A; Itoi T
    Medicine (Baltimore); 2021 Jul; 100(28):e26651. PubMed ID: 34260567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications.
    Cai M; Huang W; Lin C; Li Z; Qian J; Huang M; Zeng Z; Huang J; Shan H; Zhu K
    Eur Radiol; 2016 Feb; 26(2):370-80. PubMed ID: 26002134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.